TURKISH JOURNAL OF ONCOLOGY
PISSN : 1300-7467
EISSN : 2717-8978
TURKISH JOURNAL OF ONCOLOGY
* Home
* Aim and Scope
* Editorial Board
* Consulting Editors
* Table of Contents
* Informations For Authors
* Retractions
* Contact
Current Issue
Forthcoming Issue
Archive
Supplements
Copyright Transfer Form
Search
Türkçe
The Official Journal of Turkish Society for Radiation Oncology
TURKISH JOURNAL OF ONCOLOGY 2019 , Vol 34 , Num 1 Turkish Abstract Abstract Full Text PDF Similar Articles Mail to Author
Breast Brachytherapy and a Case Report
İlknur ALSAN ÇETİN1,Seden KÜÇÜCÜK2,Işık ASLAY3
1Department of Radiation Oncology, Marmara University, İstanbul-Turkey
2Department of Radiation Oncology, İstanbul University, İstanbul-Turkey
3Department of Radiation Oncology, Acıbadem Hospital, İstanbul-Turkey DOI : 10.5505/tjo.2019.1927 Summary For women who had breast-conserving surgery (BCS), brachytherapy can be used along with external beam radiation as a way to add an extra boost of radiation to the tumor site. It may also be used as a form of accelerated partial breast irradiation. Tumor size, location and other factors may affect brachytherapy decision. The patient was 47 years old and applied to Istanbul University Oncology Institute Radiation Oncology Department. A mass in the upper outer quadrant was detected. Invasive ductal cancer was diagnosed with biopsy. MKC and sentinel lymph node biopsy were performed in 2013. Histological and nuclear grade II, ER (+++), PG (+++), cerbB2 (-), lymphovascular invasion (-), pT1N0 was revealed. In 2013, 50 Gy/25 frx ERT was applied to the left breast tangent. After 16 days, HDR was performed twice daily (BID) (4x3Gy), 14-channel ISI breast implants. The reference dose is defined as 3 Gy GTV.
Home Aim and Scope Editorial Board Consulting Editors Table of Contents Informations For Authors Retractions Contact
TURKISH JOURNAL OF ONCOLOGY
Home
Aim and Scope
Editorial Board
Consulting Editors
Table of Contents
Informations For Authors
Retractions
Contact
Current Issue
Forthcoming Issue
Forthcoming Issue
Archive
Supplements
Copyright Transfer Form
Search
Türkçe
Online Manuscript Review
The Official Journal of Turkish Society for Radiation Oncology
Turkish Abstract
Abstract
Full Text
Similar Articles
Mail to Author
Summary
Home
Aim and Scope
Editorial Board
Consulting Editors
Table of Contents
Informations For Authors
Retractions
Contact
İlknur Alsan Çeti̇n1; Seden Küçücük2; Işık Aslay3
1Department of Radiation Oncology, Marmara University, İstanbul-Turkey
2Department of Radiation Oncology, İstanbul University, İstanbul-Turkey
3Department of Radiation Oncology, Acıbadem Hospital, İstanbul-Turkey
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2019. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
For women who had breast-conserving surgery (BCS), brachytherapy can be used along with external beam radiation as a way to add an extra boost of radiation to the tumor site. It may also be used as a form of accelerated partial breast irradiation. Tumor size, location and other factors may affect brachytherapy decision. The patient was 47 years old and applied to Istanbul University Oncology Institute Radiation Oncology Department. A mass in the upper outer quadrant was detected. Invasive ductal cancer was diagnosed with biopsy. MKC and sentinel lymph node biopsy were performed in 2013. Histological and nuclear grade II, ER (+++), PG (+++), cerbB2 (-), lymphovascular invasion (-), pT1N0 was revealed. In 2013, 50 Gy/25 frx ERT was applied to the left breast tangent. After 16 days, HDR was performed twice daily (BID) (4x3Gy), 14-channel ISI breast implants. The reference dose is defined as 3 Gy GTV.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer